Deuruxolitinib for treating severe alopecia areata

Evaluation committee members

This topic was considered as a cost-comparison evaluation by the chair and vice chair of the highly specialised technologies evaluation committee.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

Chair

Paul Arundel
Chair, highly specialised technologies evaluation committee

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager, and an associate director or principal technical adviser.

Emma Bajela
Technical lead

Caron Jones
Technical adviser

Jennifer Upton
Project manager

Lizzie Walker
Principal technical adviser

ISBN: 978-1-4731-9608-7